Next-Generation Fraud Detection Product Uses AI to Detect and Help Clients Prevent Synthetic Identity Fraud, One of the Fastest-Growing Identity Threats ATLANTANext-Generation Fraud Detection Product Uses AI to Detect and Help Clients Prevent Synthetic Identity Fraud, One of the Fastest-Growing Identity Threats ATLANTA

Equifax Introduces Enhanced Synthetic Identity Fraud Detection

3 min read

Next-Generation Fraud Detection Product Uses AI to Detect and Help Clients Prevent Synthetic Identity Fraud, One of the Fastest-Growing Identity Threats

ATLANTA, Jan. 23, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) announced the launch of Synthetic Identity Risk, a next-generation fraud detection product that leverages AI capabilities to help businesses identify and prevent synthetic identity fraud, a complex and growing challenge that forces lenders to absorb significant financial loss. This new product leverages sophisticated machine learning algorithms to uncover fraud patterns that traditional methods may miss, detecting and flagging potential fraudulent activity before it impacts a company’s bottom line.

Synthetic identity fraud occurs when fraudsters couple elements of a real identity and manufactured components to create a new, fictitious identity. These fabricated identities are used to fraudulently open credit accounts or obtain loans, on which the fraudsters eventually stop making payments. Because these fabricated applicants often appear legitimate, synthetic identities can go undetected for long periods of time, leaving lenders exposed to significant charge-offs and revenue loss. According to Equifax data, the average cost or charged-off loss per known synthetic identity is approximately $13,000.1

Leveraging patent-pending technology, Synthetic Identity Risk analyzes identity data, credit history and behavioral signals to assess the likelihood of synthetic identity activity. Synthetic Identity Risk can be used to detect potential fraud at account opening or it can be used as an account management tool to continuously identify hidden portfolio risk. Applying a holistic approach allows enterprises to make informed, real-time decisions about identity verification and fraud prevention.

“Synthetic identity fraud is a rapidly growing threat impacting the consumer lending ecosystem,” said Felipe Castillo, Chief Product Officer for U.S. Information Solutions at Equifax. “With Synthetic Identity Risk, Equifax strengthens lenders’ fraud defenses, helping them to uncover hidden risks and ultimately shift from reactive loss recovery to proactive prevention. In doing so, they not only reduce their financial losses but they safeguard and build long-term trust with their legitimate customers.”

For more information about Synthetic Identity Risk, please visit our website.

1Average cost (or loss being charged off) for tradelines on or after January 1, 2022 reported to Equifax Consumer Credit Files as of December 2025.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com

FOR MORE INFORMATION: 
Tiffany Smith for Equifax  
mediainquiries@equifax.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-introduces-enhanced-synthetic-identity-fraud-detection-302668410.html

SOURCE Equifax Inc.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11